Matthew J Walters

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum Stress

Regulatory T Cells

Hydrogen Peroxide

Top Venues

Cancer research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Dana Piovesan, Amber E de Groot, Soonweng Cho, Amy E Anderson, Rebecca D Ray, Amita Patnaik, Paul G Foster, Casey G Mitchell, Alejandra Y Lopez Espinoza, Wandi S Zhu, Carlo E Stagnaro, Hema Singh, Xiaoning Zhao, Lisa Seitz, Nigel P C Walker, Matthew J Walters, Kelsey E Sivick
Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity without Depleting Regulatory T Cells. Cancer research 84 (12) (2024)
Dana Piovesan, Amber E de Groot, Soonweng Cho, Amy E Anderson, Rebecca D Ray, Amita Patnaik, Paul G Foster, Casey G Mitchell, Alejandra Y Lopez Espinoza, Wandi S Zhu, Carlo E Stagnaro, Hema Singh, Xiaoning Zhao, Lisa Seitz, Nigel P C Walker, Matthew J Walters, Kelsey E Sivick
Fc-silent anti-TIGIT antibodies potentiate anti-tumor immunity without depleting regulatory T cells. Cancer research (2024)
Amy E Anderson, Kaustubh Parashar, Ke Jin, Julie Clor, Carlo E Stagnaro, Urvi Vani, Jaskirat Singh, Ada Chen, Yihong Guan, Priyanka Talukdar, Pavithra Sathishkumar, Damie J Juat, Hema Singh, Ritu Kushwaha, Xiaoning Zhao, Angelo Kaplan, Lisa Seitz, Matthew J Walters, Ester Fernandez-Salas, Nigel P C Walker, Christine E Bowman
Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors. Molecular cancer therapeutics (2024)
Dana Piovesan, Joanne B L Tan, Annette Becker, Jesus Banuelos, Nell N Narasappa, Daniel DiRenzo, Kristen Zhang, Ada Chen, Elaine Ginn, Akshata R Udyavar, Fangfang Yin, Susan L Paprcka, Bhamini Purandare, Timothy W Park, Nikki Kimura, Jaroslaw Kalisiak, Stephen W Young, Jay P Powers, Uli Schindler, Kelsey E Sivick, Matthew J Walters
Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity. Molecular cancer therapeutics 21 (6) (2022)